Skip to main
IMVT

Immunovant Inc (IMVT) Market Capitalization Overview

Market Cap: $5.25B as of Jan 9, 2026

$5.25B
$1.26B (31.46%)past month
As of Jan 9, 2026, Immunovant Inc (IMVT) has a market capitalization of $5.25B. Over the past 30 days, its market cap has increased by 30.91%, while in the last 12 months, it has increased by 2.4%.

Market capitalization represents the total value of Immunovant Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Immunovant Inc (IMVT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Immunovant Inc (IMVT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Immunovant Inc (IMVT) Market Cap History

DateMarket CapChange
Dec 1, 2025$3.99B-3.80%
Nov 3, 2025$4.15B+45.53%
Oct 1, 2025$2.85B+8.43%
Sep 2, 2025$2.63B-2.25%
Aug 1, 2025$2.69B-2.64%
Jul 1, 2025$2.77B+4.80%
Jun 2, 2025$2.64B-2.48%
May 1, 2025$2.71B+4.61%
Apr 1, 2025$2.59B-17.57%
Mar 3, 2025$3.14B-11.33%
Feb 3, 2025$3.54B-4.46%
Jan 2, 2025$3.70B-12.50%

Immunovant Inc (IMVT) End of Year Market Cap History

DateMarket CapChange
2026$5.25B+2.40%
2025$5.13B+40.86%
2024$3.64B-40.34%
2023$6.10B+165.79%
2022$2.30B+134.03%
2021$979.80M

FAQs About Immunovant Inc (IMVT) Market Cap

As of Jan 9, 2026, the market capitalization of Immunovant Inc (IMVT) is $5.25B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Immunovant Inc’s market capitalization has increased by 31.46%, changing from $3.99B to $5.25B as of Jan 9, 2026.

In the last 3 months, Immunovant Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Immunovant Inc’s market capitalization increased from $3.64B in January to $5.13B in December, reflecting a 40.86% change.

In the past five years, Immunovant Inc (IMVT) has had a compound annual growth rate (CAGR) of 39.20% in market capitalization. This means its market cap has grown at an average rate of 39.20% per year.

Immunovant Inc (IMVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.